| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/03/2007 | CN101048401A Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 10/03/2007 | CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors |
| 10/03/2007 | CN101045825A Azo metal chelate dyestuff and optical recording medium |
| 10/03/2007 | CN101045727A Inhibitors of tyrosine kinases |
| 10/03/2007 | CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3 |
| 10/03/2007 | CN100340557C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 10/03/2007 | CN100340548C Novel arylheteroalkylamine derivatives |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 10/02/2007 | US7276602 Isothiazole derivatives useful as anticancer agents |
| 10/02/2007 | US7276527 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 10/02/2007 | US7276526 Comprising a cyclopropyl, and aryl or heteroaryl substitutions; treating neurological and psychological disorders |
| 10/02/2007 | US7276524 Compounds as antumor agents or immunosuppressants |
| 10/02/2007 | US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity |
| 10/02/2007 | US7276502 For therapy and prophylaxis of immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, proliferative disorders, immunologically-mediated diseases, or respiratory disorders |
| 10/02/2007 | CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 10/02/2007 | CA2283242C Pesticidal 1-arylpyrazoles |
| 10/02/2007 | CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 10/02/2007 | CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation |
| 10/02/2007 | CA2027341C Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives |
| 09/27/2007 | WO2007109786A2 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 09/27/2007 | WO2007109334A2 Sip receptor modulating compounds and use thereof |
| 09/27/2007 | WO2007108744A2 Novel quinazolines as 5-ht6 modulators |
| 09/27/2007 | WO2007108743A2 Novel quinazolines as 5-ht6 modulators ii |
| 09/27/2007 | WO2007108569A1 Novel substituted-1, 1-dioxo-benzo[1,2,4]thiadizin-3-ones, preparation method thereof, and pharmaceutical composition containing the same |
| 09/27/2007 | WO2007107539A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | WO2007107470A2 Pyrazoles as 11-beta-hsd-1 |
| 09/27/2007 | WO2007107354A1 Rosiglitazone hydrochloride hemihydrate |
| 09/27/2007 | WO2007085356A3 Insecticidal (heteroarylalkyl)alkane thio and oxo amine derivatives |
| 09/27/2007 | WO2007022241A3 Novel high affinity quinoline-based kinase ligands |
| 09/27/2007 | US20070225504 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 09/27/2007 | US20070225501 Process for the Preparation of Rosiglitazone |
| 09/27/2007 | US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 09/27/2007 | US20070225494 Process for the Preparation of 11-(4-[2-(2-Hydroxyethoxy)Ethyl]-I-Piperazinyl)Dibenzo[b,f][I,4]Thiazepine |
| 09/27/2007 | US20070225337 Novel Co-Precipitate of Amorphous Rosiglitazone |
| 09/27/2007 | US20070225332 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 09/27/2007 | US20070225321 2,4-pyrimidinediamine compounds and their uses |
| 09/27/2007 | US20070225307 C-met modulators and method of use |
| 09/27/2007 | US20070225297 Deuterated hepatitis C protease inhibitors |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225295 Ziprasidone Hydrochloride Polymorph and Process for Its Preparation |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/27/2007 | US20070225286 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 09/27/2007 | US20070225280 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome |
| 09/27/2007 | US20070225272 CGRP receptor antagonists |
| 09/27/2007 | US20070225269 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides |
| 09/27/2007 | US20070225265 Novel Macrocycles for the Treatment of Cancer |
| 09/27/2007 | CA2679980A1 S1p receptor modulating compounds and use thereof |
| 09/27/2007 | CA2646627A1 Rosiglitazone hydrochloride hemihydrate |
| 09/27/2007 | CA2646585A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/26/2007 | EP1836201A1 Pyrrolidine inhibitors of iap |
| 09/26/2007 | EP1836200A1 Benzisothiazole-1, 1-dioxide acting as antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 09/26/2007 | EP1836199A1 Thiazole and isothiazole derivatives that modulate the activity of cdk, gsk and aurora kinases |
| 09/26/2007 | EP1836198A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments |
| 09/26/2007 | EP1836188A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 09/26/2007 | EP1836183A2 Spiro derivatives as lipoxygenase inhibitors |
| 09/26/2007 | EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 09/26/2007 | EP1836176A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1554250B1 Novel lactams and uses thereof |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
| 09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | CN101041659A Pioglitazone derivative and pharmaceutical composition thereof |
| 09/26/2007 | CN101041658A Resolution method for 2-hetero ring substituted dihydropyrimidine racemic compounds |
| 09/26/2007 | CN101041657A Imines derivative of 4,5-disubstituted-2-aminothiazole having anticancer action and preparation thereof |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/25/2007 | US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273881 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 09/25/2007 | US7273880 Selective NPY (Y5) antagonists |
| 09/25/2007 | US7273879 3-Thio-5-phenylalkoxy-substituted-1,2,4-thiadiazoles, e.g., 5-benzyloxy-3-methylthio- (or 3-acetoxymethyl)thio-1,2,4-thiadiazole; used for controlling arthropod pests |
| 09/25/2007 | US7273876 Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use |
| 09/25/2007 | US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 09/25/2007 | US7273866 2-aryl thiazole derivatives as KCNQ modulators |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273862 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production |
| 09/25/2007 | CA2164918C Thiol compounds |
| 09/20/2007 | WO2007106879A2 Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide and related metabolites thereof |
| 09/20/2007 | WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | WO2007106016A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007105814A1 Substituted isoxazoline compound and pest control agent |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |